PRO-DEX INC (PDEX) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:PDEX • US74265M2052

40.03 USD
-0.03 (-0.07%)
At close: Feb 3, 2026
40.03 USD
0 (0%)
After Hours: 2/3/2026, 4:30:00 PM
Fundamental Rating

5

Taking everything into account, PDEX scores 5 out of 10 in our fundamental rating. PDEX was compared to 186 industry peers in the Health Care Equipment & Supplies industry. PDEX scores excellent on profitability, but there are some minor concerns on its financial health. PDEX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • PDEX had positive earnings in the past year.
  • In the past year PDEX has reported a negative cash flow from operations.
  • In the past 5 years PDEX has always been profitable.
  • In multiple years PDEX reported negative operating cash flow during the last 5 years.
PDEX Yearly Net Income VS EBIT VS OCF VS FCFPDEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M -10M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 17.41%, PDEX belongs to the top of the industry, outperforming 97.85% of the companies in the same industry.
  • PDEX has a Return On Equity of 26.96%. This is amongst the best in the industry. PDEX outperforms 97.85% of its industry peers.
  • PDEX's Return On Invested Capital of 16.51% is amongst the best of the industry. PDEX outperforms 96.24% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for PDEX is significantly above the industry average of 8.80%.
  • The 3 year average ROIC (14.16%) for PDEX is below the current ROIC(16.51%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 17.41%
ROE 26.96%
ROIC 16.51%
ROA(3y)10.79%
ROA(5y)11.4%
ROE(3y)17.93%
ROE(5y)20.5%
ROIC(3y)14.16%
ROIC(5y)12.68%
PDEX Yearly ROA, ROE, ROICPDEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • PDEX has a Profit Margin of 15.94%. This is amongst the best in the industry. PDEX outperforms 92.47% of its industry peers.
  • PDEX's Profit Margin has declined in the last couple of years.
  • PDEX has a Operating Margin of 15.36%. This is amongst the best in the industry. PDEX outperforms 83.87% of its industry peers.
  • PDEX's Operating Margin has declined in the last couple of years.
  • The Gross Margin of PDEX (28.09%) is worse than 76.88% of its industry peers.
  • In the last couple of years the Gross Margin of PDEX has declined.
Industry RankSector Rank
OM 15.36%
PM (TTM) 15.94%
GM 28.09%
OM growth 3Y9.36%
OM growth 5Y-4.56%
PM growth 3Y7.44%
PM growth 5Y-5.13%
GM growth 3Y-2.11%
GM growth 5Y-4.93%
PDEX Yearly Profit, Operating, Gross MarginsPDEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

6

2. Health

2.1 Basic Checks

  • PDEX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for PDEX has been reduced compared to 1 year ago.
  • Compared to 5 years ago, PDEX has less shares outstanding
  • The debt/assets ratio for PDEX is higher compared to a year ago.
PDEX Yearly Shares OutstandingPDEX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M
PDEX Yearly Total Debt VS Total AssetsPDEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • PDEX has an Altman-Z score of 6.66. This indicates that PDEX is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of PDEX (6.66) is better than 83.33% of its industry peers.
  • A Debt/Equity ratio of 0.21 indicates that PDEX is not too dependend on debt financing.
  • PDEX has a Debt to Equity ratio (0.21) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 6.66
ROIC/WACC1.63
WACC10.1%
PDEX Yearly LT Debt VS Equity VS FCFPDEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M

2.3 Liquidity

  • PDEX has a Current Ratio of 3.73. This indicates that PDEX is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 3.73, PDEX is doing good in the industry, outperforming 65.05% of the companies in the same industry.
  • A Quick Ratio of 2.14 indicates that PDEX has no problem at all paying its short term obligations.
  • PDEX has a Quick ratio (2.14) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 3.73
Quick Ratio 2.14
PDEX Yearly Current Assets VS Current LiabilitesPDEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

4

3. Growth

3.1 Past

  • PDEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 61.19%, which is quite impressive.
  • The Earnings Per Share has been growing by 10.96% on average over the past years. This is quite good.
  • PDEX shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.68%.
  • The Revenue has been growing by 13.84% on average over the past years. This is quite good.
EPS 1Y (TTM)61.19%
EPS 3Y35.1%
EPS 5Y10.96%
EPS Q2Q%8.2%
Revenue 1Y (TTM)23.68%
Revenue growth 3Y16.57%
Revenue growth 5Y13.84%
Sales Q2Q%11.12%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-4.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.48%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PDEX Yearly Revenue VS EstimatesPDEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
PDEX Yearly EPS VS EstimatesPDEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 12.35, PDEX is valued correctly.
  • Based on the Price/Earnings ratio, PDEX is valued cheaply inside the industry as 93.01% of the companies are valued more expensively.
  • PDEX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.41.
  • With a Price/Forward Earnings ratio of 16.49, PDEX is valued correctly.
  • PDEX's Price/Forward Earnings ratio is rather cheap when compared to the industry. PDEX is cheaper than 86.56% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 25.64. PDEX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 12.35
Fwd PE 16.49
PDEX Price Earnings VS Forward Price EarningsPDEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PDEX indicates a rather cheap valuation: PDEX is cheaper than 90.86% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.24
PDEX Per share dataPDEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • PDEX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.13
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • PDEX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

PRO-DEX INC

NASDAQ:PDEX (2/3/2026, 4:30:00 PM)

After market: 40.03 0 (0%)

40.03

-0.03 (-0.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-29
Earnings (Next)04-29
Inst Owners31.88%
Inst Owner Change-6.38%
Ins Owners36.03%
Ins Owner Change1.64%
Market Cap130.50M
Revenue(TTM)66.59M
Net Income(TTM)11.19M
Analysts82.86
Price Target57.12 (42.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)74.8%
Min EPS beat(2)-24.91%
Max EPS beat(2)174.51%
EPS beat(4)3
Avg EPS beat(4)69.51%
Min EPS beat(4)-24.91%
Max EPS beat(4)174.51%
EPS beat(8)5
Avg EPS beat(8)44.11%
EPS beat(12)7
Avg EPS beat(12)20.2%
EPS beat(16)8
Avg EPS beat(16)16.17%
Revenue beat(2)1
Avg Revenue beat(2)7.28%
Min Revenue beat(2)-4.18%
Max Revenue beat(2)18.74%
Revenue beat(4)2
Avg Revenue beat(4)7.58%
Min Revenue beat(4)-4.18%
Max Revenue beat(4)19.3%
Revenue beat(8)6
Avg Revenue beat(8)12.93%
Revenue beat(12)9
Avg Revenue beat(12)11.32%
Revenue beat(16)12
Avg Revenue beat(16)11.48%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 12.35
Fwd PE 16.49
P/S 1.86
P/FCF N/A
P/OCF N/A
P/B 3.14
P/tB 3.14
EV/EBITDA 10.24
EPS(TTM)3.24
EY8.09%
EPS(NY)2.43
Fwd EY6.06%
FCF(TTM)-0.67
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS21.54
BVpS12.73
TBVpS12.73
PEG (NY)N/A
PEG (5Y)1.13
Graham Number30.47
Profitability
Industry RankSector Rank
ROA 17.41%
ROE 26.96%
ROCE 21.27%
ROIC 16.51%
ROICexc 20.85%
ROICexgc 20.86%
OM 15.36%
PM (TTM) 15.94%
GM 28.09%
FCFM N/A
ROA(3y)10.79%
ROA(5y)11.4%
ROE(3y)17.93%
ROE(5y)20.5%
ROIC(3y)14.16%
ROIC(5y)12.68%
ROICexc(3y)16.6%
ROICexc(5y)14.6%
ROICexgc(3y)16.62%
ROICexgc(5y)14.63%
ROCE(3y)18.25%
ROCE(5y)16.34%
ROICexgc growth 3Y23.73%
ROICexgc growth 5Y-8.41%
ROICexc growth 3Y23.84%
ROICexc growth 5Y-8.25%
OM growth 3Y9.36%
OM growth 5Y-4.56%
PM growth 3Y7.44%
PM growth 5Y-5.13%
GM growth 3Y-2.11%
GM growth 5Y-4.93%
F-Score6
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA 0.72
Cap/Depr 73.12%
Cap/Sales 1.3%
Interest Coverage 12.57
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.73
Quick Ratio 2.14
Altman-Z 6.66
F-Score6
WACC10.1%
ROIC/WACC1.63
Cap/Depr(3y)99.37%
Cap/Depr(5y)344.26%
Cap/Sales(3y)1.93%
Cap/Sales(5y)6.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.19%
EPS 3Y35.1%
EPS 5Y10.96%
EPS Q2Q%8.2%
EPS Next Y-4.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.68%
Revenue growth 3Y16.57%
Revenue growth 5Y13.84%
Sales Q2Q%11.12%
Revenue Next Year4.48%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.16%
EBIT growth 3Y27.48%
EBIT growth 5Y8.65%
EBIT Next Year10.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-206.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-142.63%
OCF growth 3YN/A
OCF growth 5YN/A

PRO-DEX INC / PDEX FAQ

Can you provide the ChartMill fundamental rating for PRO-DEX INC?

ChartMill assigns a fundamental rating of 5 / 10 to PDEX.


What is the valuation status for PDEX stock?

ChartMill assigns a valuation rating of 5 / 10 to PRO-DEX INC (PDEX). This can be considered as Fairly Valued.


Can you provide the profitability details for PRO-DEX INC?

PRO-DEX INC (PDEX) has a profitability rating of 7 / 10.


What is the financial health of PRO-DEX INC (PDEX) stock?

The financial health rating of PRO-DEX INC (PDEX) is 6 / 10.


What is the expected EPS growth for PRO-DEX INC (PDEX) stock?

The Earnings per Share (EPS) of PRO-DEX INC (PDEX) is expected to decline by -4.43% in the next year.